Inactive Instrument

Highlights DEINOVE OTC Markets

Equities

DNVVF

FR0010879056

Highlights

Unlock all the news: Be the first to know and act before the market!

Court Reserves Decision On Deinove Receivership Proceedings	23-01-16	MT
Deinove SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-06	CI
Deinove SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-08	CI
Deinove SA Announces the Extension of Its Clinical Trial to Canada	22-04-07	CI
Deinove SA Announces A Favorable Opinion from the DSMBfor the Continuation of the Phase II Clinical Trial of DNV3837 in Clostridioides Difficile Infections	22-01-06	CI
Deinove Announces Collaboration with Max Mousseron Institute of Biomolecules and the LMP of the University of Montpellier	21-06-30	CI
Deinove SA Announces Consolidated Financial Results for the Year Ended December 31, 2020	21-03-25	CI
Deinove SA Signs an Evaluation and Technology Development License with DSM	20-11-19	CI
Deinove Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-30	CI
DEINOVE Pursues Phase II Clinical Trial of its Antibiotic Candidate DNV3837	20-07-15	CI
Deinove Sa Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI
DEINOVE Announces the Official Launch of Luminity	20-04-23	CI
DEINOVE Provides Update on BIOME Oléoactif	20-03-18	CI
Deinove SA Expands its Range of Cosmetic Active Ingredients	20-02-19	CI
Sharon Laboratories Capitalizes on Deinove to Sustain Its Development Activities	20-02-06	CI
DEINOVE Announces the Inclusion of the First Patient in the Phase II Trial Testing DNV3837	20-01-27	CI
DEINOVE Announces the Production of New Industrial Batch of Phyt-N-Resist	20-01-22	CI
Deinove Announces Consolidated Earnings Results for the Six Months Ended June 30, 2019	19-09-26	CI
Deinove Announces Integration of CRISPR-case9 Technology to Accelerate the Discovery of Innovative Antibiotics	19-09-23	CI
DEINOVE Announces DNV3681's Exceptional Activity Against Bioterrorist Threats Presented at ASM Microbe 2019	19-06-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DEINOVE OTC Markets

Equities

DNVVF

FR0010879056

Highlights

Filters